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P U B L I S H E D B Y E L S E V I E R I N C .LettersThe Natural Course of
Healthy Obesity Over
20 YearsIntense interest surrounds the “healthy” obese
phenotype, which is deﬁned as obesity in the absence
of metabolic risk factor clustering (1). Efforts to un-
derstand the cardiovascular consequences of healthy
obesity are ongoing (2); however, its conceptual val-
idity and clinical value rest on the assumption that
it is a stable physiological state, rather than a tran-
sient phase of obesity-associated metabolic deterio-
ration. Therefore, a fundamental question is whether
healthy obese adults maintain this metabolically
healthy proﬁle over the long term or naturally tran-
sition into unhealthy obesity over time. Few studies
have examined this; in those that have, durations of
follow-up have been modest, with none exceeding
10 years (3,4). Accordingly, we aimed to describe the
natural course of healthy obesity over 2 decades in a
large population-based study.
The Whitehall II cohort study of British govern-
ment workers provided objectively measured
anthropometric and metabolic risk factor data.
“Obese” was deﬁned as body mass index $30 kg/m2.
“Metabolically healthy” was deﬁned as having <2 of
the following: high-density lipoprotein cholesterol
level <1.03 mmol/l (men) and <1.29 mmol/l (women);
blood pressure $130/85 mm Hg or use of antihyper-
tensive medication; fasting plasma glucose level
$5.6 mmol/l or use of antidiabetic medication;
triacylglycerol level $1.7 mmol/l; and homeostatic
model assessment of insulin resistance >2.87 (base-
line 90th percentile value) (1).
Participants with data on obesity and metabolic
status at baseline and all follow-up examinations
were analyzed. Cross-tabulations were used to de-
scribe the proportion of participants according to
their baseline (1992/1994) obesity and metabolic
status in each category after 5-year (1997/1999),
10-year (2002/2004), 15-year (2007/2009), and
20-year (2012/2014) follow-up examinations. Log
binomial models were used to estimate age-, sex-,
and ethnicity-adjusted prevalence ratios with 95%
conﬁdence intervals for unhealthy obesity at eachfollow-up, excluding unhealthy obese adults at
baseline.
Descriptive analyses were repeated using maximum
samples of healthy obese adults on the basis of duration
of follow-up, allowing different baseline and follow-up
points across the 20-year period. For example, the
15-year healthy obese sample included transitions from
1992/1994, to 2007/2009, or from 1997/1999 to 2012/
2014. Analyses were performed using SPSS software
version 19.0 (IBM, Armonk, New York), with p < 0.05
indicating statistical signiﬁcance.
Our primary sample (n ¼ 2,521; 39 to 62 years of
age; 75% male) included 66 healthy obese adults at
baseline (36.5% of the obese). Of these subjects, 21
(31.8%) were unhealthy obese after 5 years, and 27
(40.9%), 23 (34.8%), and 34 (51.5%) were unhealthy
obese after 10, 15, and 20 years, respectively (Table 1).
The proportion of healthy obese adults who were
healthy nonobese at follow-up was 6.1%, 4.5%, 6.1%,
and 10.6% after 5, 10, 15, and 20 years respectively.
The age-, sex-, and ethnicity-adjusted prevalence
of unhealthy obesity after 5 years was 11.80 (95%
conﬁdence interval [CI]: 7.28 to 19.11) times higher
in baseline healthy obese adults compared with
healthy nonobese subjects. The corresponding prev-
alence ratio was 8.09 (95% CI: 5.54 to 11.81) after
10 years, 6.64 (95% CI: 4.43 to 9.96) after 15 years,
and 7.74 (95% CI: 5.53 to 10.85) after 20 years.
Subsidiary analyses using maximum samples pro-
duced similar results. Of the 389 healthy obese
adults with 5-year data, 35.2% were unhealthy
obese after 5 years. This proportion was 34.7% after
10 years (sample n ¼ 317), 37.9% after 15 years (sample
n ¼ 224), and 48.1% after 20 years (sample n ¼ 106).
After 20 years, approximately one-half of healthy
obese adults were unhealthy obese, and only 10%were
healthy nonobese. Healthy obese adults were nearly 8
times more likely to progress to an unhealthy
obese state after 20 years than healthy nonobese
adults, and these subjects were consistently more
likely to make this adverse transition than unhealthy
nonobese adults. Progressions from healthy to un-
healthy obesity also increased steadily with increasing
follow-up duration when using maximum samples of
healthy obese adults over the follow-up period.
Some evidence suggests that stability is associated
with a more favorable fat distribution in the form
TABLE 1 Changes in Metabolic and Obesity Status Over 20 Years of Follow-Up Among Adults Between 39 and 62 Years of Age at Baseline
in the Whitehall II Cohort Study of British Government Workers (N ¼ 2,521)
Status at Baseline
Status at Follow-Up Prevalence Ratio for Being
Unhealthy Obese at Follow-Up*
(95% CI)Healthy Nonobese Unhealthy Nonobese Healthy Obese Unhealthy Obese
5-Year Follow-Up
Healthy nonobese (n ¼ 1,677) 1,350 (80.5) 234 (14) 52 (3.1) 41 (2.4) 1.00
Unhealthy nonobese (n ¼ 663) 249 (37.6) 331 (49.9) 24 (3.6) 59 (8.9) 3.97 (2.67–5.90)
Healthy obese (n ¼ 66) 4 (6.1) 0 (0) 41 (62.1) 21 (31.8) 11.80 (7.28–19.11)
Unhealthy obese (n ¼ 115) 9 (7.8) 9 (7.8) 20 (17.4) 77 (67)
10-Year Follow-Up
Healthy nonobese (n ¼ 1,677) 1,199 (71.5) 325 (19.4) 76 (4.5) 77 (4.6) 1.00
Unhealthy nonobese (n ¼ 663) 197 (29.7) 348 (52.5) 14 (2.1) 104 (15.7) 3.70 (2.77–4.93)
Healthy obese (n ¼ 66) 3 (4.5) 1 (1.5) 35 (53) 27 (40.9) 8.09 (5.54–11.81)
Unhealthy obese (n ¼ 115) 10 (8.7) 9 (7.8) 21 (18.3) 75 (65.2)
15-Year Follow-Up
Healthy nonobese (n ¼ 1,677) 1,237 (73.8) 276 (16.5) 82 (4.9) 82 (4.9) 1.00
Unhealthy nonobese (n ¼ 663) 232 (35) 311 (46.9) 23 (3.5) 97 (14.6) 3.23 (2.42–4.30)
Healthy obese (n ¼ 66) 4 (6.1) 3 (4.5) 36 (54.5) 23 (34.8) 6.64 (4.43–9.96)
Unhealthy obese (n ¼ 115) 12 (10.4) 4 (3.5) 22 (19.1) 77 (67)
20-Year Follow-Up
Healthy nonobese (n ¼ 1,677) 1,128 (67.3) 372 (22.2) 76 (4.5) 101 (6) 1.00
Unhealthy nonobese (n ¼ 663) 203 (30.6) 336 (50.7) 20 (3) 104 (15.7) 2.78 (2.14–3.62)
Healthy obese (n ¼ 66) 7 (10.6) 0 (0) 25 (37.9) 34 (51.5) 7.74 (5.53–10.85)
Unhealthy obese (n ¼ 115) 10 (8.7) 15 (13) 21 (18.3) 69 (60)
Values are n (%) or prevalence ratio (95% CI). *Models exclude unhealthy obese subjects at baseline (remaining n ¼ 2,406) and are adjusted for age, sex, and ethnicity.
CI ¼ conﬁdence interval.
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102of lower waist circumference (4), and thus it may be
possible to increase stability in healthy obesity over
time. However, our results, which were obtained with
a longer, more detailed follow-up than any previous
study, suggest that long-term stability is the excep-
tion, not the norm. The natural course of healthy
obesity is progression to metabolic deterioration.
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